News Detail

12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga · 3d ago

Listen to the news

Gainers

Propanc Biopharma (NASDAQ:PPCB) shares increased by 15.8% to $4.25 during Tuesday's after-market session. The market value of their outstanding shares is at $67.9 million.
enVVeno Medical (NASDAQ:NVNO) stock rose 14.04% to $4.75. The market value of their outstanding shares is at $87.5 million.
Adicet Bio (NASDAQ:ACET) stock moved upwards by 9.77% to $0.72. The company's market cap stands at $60.3 million.
Chemomab Therapeutics (NASDAQ:CMMB) shares rose 9.67% to $1.02. The company's market cap stands at $17.7 million. As per the news, the Q2 earnings report came out 3 days ago.
Longevity Health Holdings (NASDAQ:XAGE) stock rose 9.63% to $2.83. The company's market cap stands at $3.6 million.
BioLine Rx (NASDAQ:BLRX) stock moved upwards by 6.68% to $3.99. The market value of their outstanding shares is at $14.2 million. The company's, Q2 earnings came out 3 days ago.

Losers

Celldex Therapeutics (NASDAQ:CLDX) shares decreased by 12.2% to $21.1 during Tuesday's after-market session. The company's market cap stands at $1.6 billion.
BiomX (AMEX:PHGE) shares declined by 9.68% to $0.49. The market value of their outstanding shares is at $13.6 million. As per the news, the Q2 earnings report came out 4 days ago.
Talphera (NASDAQ:TLPH) shares decreased by 8.74% to $0.42. The market value of their outstanding shares is at $8.8 million. The company's, Q2 earnings came out 3 days ago.
Insight Molecular (NASDAQ:IMDX) stock fell 7.7% to $2.4. The company's market cap stands at $76.4 million.
Alcon (NYSE:ALC) stock declined by 6.8% to $84.0. The market value of their outstanding shares is at $43.5 billion. As per the news, the Q2 earnings report came out today.
SILO Pharma (NASDAQ:SILO) stock decreased by 5.29% to $0.63. The market value of their outstanding shares is at $5.0 million. The company's, Q2 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.